Replies to post #188415 on Biotech Values

[DewDiligence]

I’m not agreeing with Luly—just reporting what he said today. However, it’s worth noting that (NS5A-free) Sovaldi + Olysio is a semi-bootleg regimen that doesn’t have a lot of data on efficacy in hard-to-treat subgroups.